Cargando…
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
Recent breakthroughs in tumor immunotherapy such as immune checkpoint blockade (ICB) antibodies, have demonstrated the capacity of the immune system to fight cancer in a number of malignancies such as melanoma and lung cancer. The numbers, localization and phenotypes of tumor-infiltrating lymphocyte...
Autores principales: | Maibach, Fabienne, Sadozai, Hassan, Seyed Jafari, S. Morteza, Hunger, Robert E., Schenk, Mirjam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511547/ https://www.ncbi.nlm.nih.gov/pubmed/33013886 http://dx.doi.org/10.3389/fimmu.2020.02105 |
Ejemplares similares
-
Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
por: Sadozai, Hassan, et al.
Publicado: (2017) -
IL-32γ potentiates tumor immunity in melanoma
por: Gruber, Thomas, et al.
Publicado: (2020) -
Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer
por: Zhang, Dachuan, et al.
Publicado: (2019) -
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015) -
On the Prognostic Power of Tumor-Infiltrating Lymphocytes – A Critical Commentary
por: Elkoshi, Zeev
Publicado: (2022)